|

Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study

RECRUITINGSponsored by Latin American Cooperative Oncology Group
Actively Recruiting
SponsorLatin American Cooperative Oncology Group
Started2023-11-09
Est. completion2025-06-01
Eligibility
Age18 Years+
SexFEMALE
View on ClinicalTrials.gov →

NCT05776147

Summary

The radiotherapy scheme with extreme hypofractionation has gained space in clinical practice and, therefore, it is necessary to analyze the Brazilian national experience in selected patients with breast cancer, with the aim of evaluating the oncological outcomes and toxicities with the use of this treatment protocol.

Eligibility

Age: 18 Years+Sex: FEMALE
Inclusion Criteria:

* Women over 18 years old;
* Diagnosis of breast cancer of any molecular subtype;
* Undergoing extreme hypofractionated radiotherapy (5 x 5.2Gy) postoperatively;
* Treated from December/2019 onward;
* With clinical and treatment data available in medical records.

Exclusion Criteria:

* The protocol does not provide exclusion criteria.

Conditions3

Breast CancerCancerRadiotherapy Side Effect

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.